ProMIS Neurosciences, Inc. (PMN) vs vTv Therapeutics Inc. (VTVT)

A side-by-side comparison of ProMIS Neurosciences, Inc. and vTv Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — PMN vs VTVT

growth of $100 · dividends reinvested · last 10y
PMN -92.2% (-22.5%/yr)VTVT -88.6% (-19.5%/yr)VTVT compounded faster over this window
0100200300400500Start $10020182020202220242026$8$11
PMN VTVT

PMN vs VTVT: by the numbers

  • •PMN is the larger company ($83M vs $79M market cap).
  • •Both run net losses; PMN's is the smaller (0.00% vs -12.91% net margin).

Metrics side by side

Valuation

MetricPMNVTVT
P/S ratioN/A2.13
P/B ratio1.671.00

Profitability

MetricPMNVTVT
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%-12.91%
ROE-85.48%-6.05%
ROIC-87.79%-11.48%

Growth (annualized)

MetricPMNVTVT
Revenue CAGR (5Y)N/A-18.12%
Total return CAGR (5Y)-47.05%-13.55%

Frequently asked

How have PMN and VTVT total returns compared?
Over the past 10 years, PMN delivered -22.51% and VTVT delivered -19.77% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.